Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025 Sep 2, 2025 Sep 1, 2025 Aug 28, 2025 Aug 26, 2025 Aug 25, 2025 Aug 22, 2025 Aug 21, 2025 Aug 20, 2025 Aug 19, 2025 Aug 18, 2025 Aug 15, 2025 Aug 14, 2025 Aug 13, 2025 Aug 12, 2025 Aug 11, 2025 Aug 9, 2025 Aug 8, 2025 Aug 2, 2025 Aug 1, 2025 Jul 30, 2025 Jul 29, 2025 Jul 25, 2025

23 companies Today

Aurora Cannabis Inc.

ACB Q3 2026

Reported: 2026-02-04

Aurora Cannabis Inc. delivered a strong Q3 2026 performance with a 7% increase in net revenue, driven primarily by robust international medical cannabis growth. The company reported positive free cash flow and improved margins while focusing on strategic market exits to enhance profitability.

Key takeaways

Net revenue increased by 7%, with a 12% rise in global medical cannabis sales, surpassing expectations.
Adjusted gross margin improved to 62%, supported by a strong international performance with medical cannabis margins at 69%.
Achieved positive adjusted EBITDA of $18.5 million and free cash flow of $15.5 million, maintaining a solid balance sheet with over $150 million in cash.
Initiating exits from lower-margin Canadian consumer cannabis markets to concentrate resources on higher-margin global medical cannabis growth.
Announced a new at-the-market equity program to raise up to $100 million for strategic investments including cultivation capacity enhancements.

Adient plc

ADNT Q1 2026

Reported: 2026-02-04

Adient plc demonstrated a solid start to fiscal year 2026, with a 4% year-over-year revenue increase, driven by favorable foreign exchange rates and strong growth in China.

Key takeaways

Revenue growth of 4% year-over-year, bolstered by currency impacts and significant sales in China.
Increased guidance for revenue, adjusted EBITDA, and free cash flow, reflecting confidence in production volume recovery.
Successful navigation of supply chain challenges, enhancing operational resilience.
Allocation of $25 million to shareholders through share repurchases, maintaining a strong balance sheet with $855 million in cash.
Anticipated revenue impact of $500 million from onshoring initiatives over the next fiscal years, with potential updates on new business wins expected soon.

Amcor plc

AMCR Q2 2026

Reported: 2026-02-04

Amcor's Q2 FY2026 results reflect robust integration following the Berry acquisition, with adjusted EPS up 7% year-over-year and strong progress toward synergy realization.

Key takeaways

Adjusted EPS of $0.86, maintaining momentum towards double-digit growth for the fiscal year.
Synergies accelerated to $55 million in Q2, totaling $93 million for the first half, reinforcing confidence in meeting $160 million synergy target for FY2026.
Free cash flow reached $289 million, with a quarterly dividend increase to $0.65 per share, underscoring commitment to shareholder returns.
Core portfolio performance outpaced overall business, with adjusted EBIT margins around 12%, reflecting effective cost management and productivity gains.
Ongoing evaluation of $2.5 billion in non-core assets aimed at positioning for sustainable long-term growth.

Atmos Energy Corporation

ATO Q1 2026

Reported: 2026-02-04

Atmos Energy reported a strong start to fiscal 2026 with net income of $403 million, benefiting from strategic investments and robust customer growth amid challenging weather conditions.

Key takeaways

Q1 earnings per share reached $2.44, a 9.4% increase year-over-year.
Capital expenditures totaled $1 billion, with over 85% allocated towards enhancing safety and reliability of infrastructure.
Customer base expanded by nearly 54,000 over the past year, underscoring steady demand for natural gas services.
Successful project completions in pipeline capacity and storage improvement enhance long-term service delivery and operational efficiency.
Ranked #1 in customer satisfaction among large utilities in the South and Midwest for four consecutive years.

Aytu Biopharma, Inc.

AYTU Q2 2026

Reported: 2026-02-04

Aytu BioPharma reported a strategically significant launch of ExuA, the first FDA-approved 5-HT1A agonist for major depressive disorder (MDD), with a focus on unmet treatment needs and a differentiated mechanism of action.

Key takeaways

ExuA addresses significant gaps in MDD treatment by targeting the 5-HT1A receptor, offering a novel approach that minimizes common side effects associated with traditional antidepressants.
The company aims for robust market penetration with a dual approach, leveraging both a dedicated sales team and a flexible contract sales organization to optimize reach and efficacy.
Clinical trials indicate that ExuA has a favorable safety profile, showing no sexual dysfunction or weight gain compared to placebo, addressing critical patient concerns.
Aytu's promotional strategy combines personal and non-personal marketing tactics to effectively elevate brand awareness and prescriber adoption in key psychiatric practices.
The launch is positioned to benefit from extensive clinical backing, with recognized experts endorsing ExuA's innovative mechanism and therapeutic potential in the MDD landscape.

Azenta Inc.

AZTA Q1 2026

Reported: 2026-02-04

Azenta, Inc. reported a first-quarter organic revenue decline of approximately 1% as anticipated, navigating a mixed macro environment while laying the groundwork for future growth and operational improvements.

Key takeaways

Consistent execution across teams is driving progress, positioning Azenta for a successful turnaround amid cautious capital spending in the life sciences sector.
Bookings were impacted by weak capital investments and a government shutdown, but the company expects future order recognition to stabilize full-year results.
The strategic focus for 2026 includes enhancing operational excellence, accelerating growth, and disciplined capital deployment to create long-term shareholder value.

The Clorox Company

CLX Q2 2026

Reported: 2026-02-04

The Clorox Company demonstrated resilience in Q2 FY2026, reaffirming guidance amidst a challenging macroeconomic landscape and ongoing ERP implementation, while signaling optimism for the future driven by strategic initiatives.

Key takeaways

Results were largely in line with expectations, indicating stability despite external pressures and the temporary effects of ERP rollouts.
The planned acquisition of Gojo Industries is aimed at strengthening Clorox's leadership in health and hygiene and unlocking long-term growth opportunities.
Sequential improvement in performance observed, with stronger share gains noted in late January, fueled by effective investments and innovation plans.
Competitive environment has stabilized to pre-COVID levels, with Clorox prepared to address intense competition in key categories.
Guidance for category growth remains projected between 0% to 1% for the fiscal year, reflecting steady consumer behavior in alignment with broader market trends.

Cencora Inc.

COR Q1 2026

Reported: 2026-02-04

Cencora, Inc. reported a strong start to fiscal 2026, achieving adjusted operating income growth of 12% and adjusted diluted EPS growth of 9% driven by strategic investments and acquisitions.

Key takeaways

Completed acquisition of OneOncology, enhancing capabilities and strengthening market position in specialty pharmaceuticals.
Raised fiscal 2026 guidance, projecting adjusted operating income growth of 11.5% to 13.5%.
Continued strength in U.S. healthcare solutions business, driven by a pharmaceutical-centric strategy and advanced analytics.
Significant advancements in clinical research and patient care through MSO expansion, positioning Cencora as a leader in the healthcare ecosystem.
Ongoing focus on enhancing patient access to innovative specialty medications and treatments through supportive operational frameworks.

Flex Ltd.

FLEX Q3 2026

Reported: 2026-02-04

Flex's third quarter fiscal 2026 showcased strong growth, with revenues reaching $7.1 billion—a year-over-year increase of 8%—and record adjusted EPS of $0.87, reflecting robust performance across diversified sectors.

Key takeaways

Adjusted operating margin improved to 6.5%, marking a record high due to effective cost management and a strategic shift toward higher-value products.
Continued expansion in data center solutions driven by AI workloads, including partnership announcements with NVIDIA and LG for modular systems and thermal management.
Strong demand in health solutions and industrial sectors, particularly in medical devices, automation, and semiconductor-related equipment, signaling broad-based momentum across the portfolio.

Fox Corporation

FOXA Q2 2026

Reported: 2026-02-04

Fox Corporation reported strong Q2 FY2026 results, showcasing broad-based revenue growth driven by robust advertising performance and increased audience engagement across its news, sports, and streaming segments.

Key takeaways

Total company advertising revenue continued to grow, with record-breaking ad revenue from Major League Baseball and impressive stats from NFL and college football.
Distribution revenue increased by 4%, with subscriber declines improving sequentially, thanks in part to the successful launch of Fox One.
Fox News maintained its position as the most-watched cable network, registering a 170% increase in social media views compared to the previous year.
Tubi achieved its most-streamed quarter ever, leading to a 19% growth in revenue and sustained EBITDA profitability for the second consecutive quarter.
Total minutes viewed across all Fox platforms rose by 15% year-over-year, underscoring the company's strong audience engagement strategy.

fuboTV Inc.

FUBO Q1 2026

Reported: 2026-02-04

Fubo's Q1 2026 results highlight the successful integration of Hulu Live, achieving $6.2 billion in pro forma revenue and 6.2 million subscribers, demonstrating robust growth and strategic synergies.

Key takeaways

Pro forma revenue totaled $6.2 billion over the past 12 months, establishing Fubo as a significant player in the Pay TV market.
The integration of Fubo's ad technology with Disney's ad server is expected to enhance CPM and fill rates significantly.
Fubo Sports has seen strong market traction, with strategic partnerships, such as with ESPN, aimed at lowering customer acquisition costs.
Record subscriber growth for Fubo's Latino product indicates successful targeting of the Spanish-speaking audience.
Content cost efficiencies and flexible pricing strategies are in focus as Fubo navigates upcoming contract renewals with major networks.

Gladstone Investment Corporation

GAIN Q3 2026

Reported: 2026-02-04

Gladstone Investment Corporation reported strong third-quarter results with adjusted net investment income (NII) of $0.21 per share and total assets growing to approximately $1.2 billion, highlighting continued portfolio expansion and resilience in a competitive M&A environment.

Key takeaways

Achieved adjusted NII of $0.21 per share, supporting a monthly distribution of $0.08.
Total assets increased by $92 million, driven by new buyout investments and significant appreciation of the existing portfolio.
Invested $163 million in four new portfolio companies during the fiscal year, exceeding previous fiscal year investment levels.
Maintained a strong pipeline for acquisitions and focused on add-on opportunities to enhance existing investments.
Portfolio net asset value rose significantly, backed by strong performance from most portfolio companies despite macroeconomic challenges.

H&R Block, Inc.

HRB Q2 2026

Reported: 2026-02-04

H&R Block's second-quarter fiscal 2026 performance showcased a robust strategy focused on enhancing client experiences and addressing tax law complexities, positioning the company for sustained growth.

Key takeaways

Introduced transformative client onboarding and service enhancements, including embedding the Second Look service into standard new client experiences to foster loyalty and retention.
Elevated DIY solutions recognized as the best online tax product for 2026, leveraging AI guidance and introducing complimentary professional reviews for early filers.
Strengthened marketing strategies to attract consumers and small businesses, aligning with their need for personalized service in an evolving landscape.

Infineon Technologies AG

IFNNY Q1 2026

Reported: 2026-02-04

Infineon Technologies reported Q1 Fiscal 2026 revenues of €3.662 billion, reflecting a seasonal decline but an uptick of 7% year-over-year, driven by strong AI-related demand and a strategic acquisition of ams-OSRAM’s sensor portfolio.

Key takeaways

Segment profit declined to €655 million, with a stable margin of 17.9%, amidst challenging market conditions.
Order backlog rose to approximately €21 billion, marking a consistent increase over six months, signaling robust future demand.
Free cash flow improved significantly to -€199 million, recovering from -€1.276 billion in the prior quarter, primarily impacted by the Marvell acquisition expenses.
The €570 million acquisition of ams-OSRAM's sensor portfolio is expected to enhance Infineon's market position in sensors and drive earnings growth in the coming years.
The automotive segment saw sales of €1.821 billion, reflecting a typical seasonal decline but a 4% increase compared to prior year’s performance.

Johnson Controls International plc

JCI Q1 2026

Reported: 2026-02-04

Johnson Controls International plc reported strong Q1 2026 results, with revenue growth of 6% and adjusted EPS up nearly 40%, exceeding expectations and showcasing a robust demand environment.

Key takeaways

Orders surged nearly 40%, building on a strong prior-year performance and contributing to a record backlog.
Adjusted EBIT margins expanded by 190 basis points to 12.4%, reflecting enhanced operational performance.
The introduction of two new chiller platforms solidifies leadership in data center cooling technology, addressing the growing need for energy efficiency and precision.
Full-year guidance raised due to strong momentum and improved execution across the business.
Continued focus on energy efficiency and decarbonization drives innovation and customer engagement in high-tech environments, including AI data centers.

Lumentum Holdings Inc.

LITE Q2 2026

Reported: 2026-02-04

Lumentum Holdings reported exceptional financial performance in Q2 FY2026, achieving record revenues of $665.5 million, a remarkable 65% year-over-year growth. The company's non-GAAP operating margin surged over 1,700 basis points, driven by strong demand across its cloud transceivers, optical circuit switches, and co-packaged optics segments.

Key takeaways

Recorded a record quarterly revenue of $665.5 million, surpassing prior projections.
Anticipates Q3 revenue guidance with an $805 million midpoint, representing an 85% year-over-year increase.
Backlog for optical circuit switches (OCS) exceeded $400 million, with significant growth expected in the second half of the calendar year.
Improved profitability in cloud transceivers through enhanced yields and lower scrap rates, positioning Lumentum as a leading supplier for network transitions to 1.6T speeds.
Initiated proactive capacity planning for upcoming scale-up optics market demands, targeting substantial growth by 2027.

NGL Energy Partners LP

NGL Q3 2026

Reported: 2026-02-04

NGL Energy Partners achieved a strong quarter, reporting a 9.2% increase in adjusted EBITDA to $172.5 million, driven by record water disposal volumes and strategic financial maneuvers.

Key takeaways

Water Solutions segment reported record adjusted EBITDA of $154.5 million, a 16.5% year-over-year increase.
Successful execution of financial strategy included redeeming 15% of Class D preferred equity and repurchasing 1.6 million common units.
Adjusted EBITDA guidance for fiscal 2026 remains steady at $650 to $660 million, with a projected first-ever EBITDA of over $700 million for fiscal 2027.
Daily water disposal volumes reached a record 3.5 million barrels on January 16, with ongoing investments enhancing operational capacity.
Continued focus on AI-driven operational efficiencies and a partnership with Natura Resources aims to bolster long-term water treatment capabilities.

Oaktree Specialty Lending Corporation

OCSL Q1 2026

Reported: 2026-02-04

Oaktree Specialty Lending Corporation reported solid first-quarter results for fiscal 2026, with adjusted net investment income increasing to $36.1 million, fully covering the quarterly dividend amidst stable earnings despite lower base rates.

Key takeaways

Adjusted net investment income rose to 41¢ per share, marking a modest increase from the previous quarter, with a declared dividend of 40¢ per share.
Funded investments totaled $314 million, a significant increase from $220 million in the prior quarter, with strong average all-in spreads and yields.
Nonaccruals remained stable, down nearly 85 basis points year-over-year, accounting for 3.1% of the total debt portfolio at fair value.
The company is optimistic about restructuring nonaccrual positions and converting them into income-producing investments.
Market trends show increasing bifurcation, with resilient businesses enjoying capital access, while underperformers face liquidity challenges; expectations for improved middle-market M&A activity are rising.

Super Micro Computer, Inc.

SMCI Q2 2026

Reported: 2026-02-04

Super Micro Computer, Inc. reported a remarkable 123% year-over-year revenue growth in Q2 FY26, driven by surging demand for AI infrastructure solutions and strategic product enhancements.

Key takeaways

Revenue reached a record TWD $12.68 billion, with substantial contributions from AI solutions and Rack Scale Systems.
The introduction of the Data Center Building Block Solution (DCBBS) is expected to accelerate deployment time and capture market share across various AI infrastructure segments.
Though facing pressure on gross margins due to shifting customer preferences and supply chain challenges, cost improvement initiatives are set to enhance profitability.
Continued focus on expanding modularized solutions and enhancing manufacturing capabilities will support long-term margin improvement.
Upcoming product launches aligned with major industry players are poised to strengthen Super Micro's market position in the AI landscape.

Sonos, Inc.

SONO Q1 2026

Reported: 2026-02-04

Sonos posted solid Q1 Fiscal 2026 results with revenue of $546 million and a remarkable 45% year-over-year growth in adjusted EBITDA, reflecting effective cost management and operational improvements.

Key takeaways

Q1 revenue exceeded guidance and gross profit dollars grew 5% year-over-year.
Adjusted EBITDA for the quarter reached $132 million, equal to the total for all of fiscal 2025.
Customer growth accelerated with over 40% year-over-year increase in new households starting with the Arrow 100 product.
Product innovation is prioritized, highlighted by the launch of Sonos Amp Multi, targeting professional installers and enhancing system integration.
Strong focus on improving customer satisfaction and system reliability through ten software upgrades, leading to increased advocacy for the Sonos brand.

Bio-Techne Corporation

TECH Q2 2026

Reported: 2026-02-04

Bio-Techne's Q2 FY2026 results showed flat organic revenue growth due to external market pressures, though large pharma demand remained strong and profitability improved, reflecting solid operational execution.

Key takeaways

Organic revenue growth was flat, impacted by timing effects from FDA Fast Track designations for key cell therapy customers.
Adjusted operating margins expanded by 100 basis points year-over-year to 31.1%, demonstrating a focus on productivity and cost management.
Large pharma revenue grew in low double digits, while emerging biotech customers faced mid-single-digit declines amid challenging funding conditions.
Significant growth in spatial biology bookings and a strong performance across Asia, particularly China, highlight emerging opportunities.
Core growth verticals now account for 47% of total revenue, with an upper teens CAGR over the past five years, driving future potential.

Take-Two Interactive Software, Inc.

TTWO Q3 2026

Reported: 2026-02-04

Take-Two Interactive exceeded expectations in Q3 fiscal 2026, reporting net bookings of $1.76 billion and raising its full-year guidance to between $6.65 billion and $7 billion.

Key takeaways

Strong performance across all labels with net bookings growth of 18% year-over-year.
Peak’s forever franchise, TuneBlast, achieved significant milestones, surpassing $3 billion in lifetime net bookings.
NBA 2K26 surpassed 8 million units sold, with expected record annual net bookings and spending for the franchise.
Grand Theft Auto series delivered robust growth, with GTA Online’s recurrent spending increasing 27%.
Direct-to-consumer initiatives and mobile offerings continue to show strong momentum, enhancing growth prospects moving forward.

Valvoline Inc.

VVV Q1 2026

Reported: 2026-02-04

Valvoline's Q1 Fiscal 2026 results showcased robust growth, with net sales increasing by 11% and adjusted EBITDA climbing significantly, fueled by effective productivity gains and network expansion.

Key takeaways

System-wide same-store sales surged 13.8%, driven by net price increases and premiumization strategies.
Net sales reached $462 million, marking a 15% growth on an adjusted basis, despite past refranchising impacts.
The company successfully integrated 162 new stores from the Breeze transaction, enhancing its network and scaling towards a 3,500-store target.
Adjusted EBITDA margin improved by 60 basis points to 25.4%, reflecting strong operational efficiency.
Valvoline’s franchise model was recognized as the top automotive services brand in Entrepreneur's Franchise 500 for the fourth consecutive year.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Support Pricing Help

Support email: support@allinvestview.com

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.